SCHEMBL6174267

SCHEMBL6174267

O=c1[nH]ncn1-c1ccc(N2CCN(c3ccc(Cl)cc3)CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.48
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
ADRB1 P08588 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
SIGMAR1 Q99720 1/20 0.47
ALDH1A1 P00352 2/20 0.47
GFER P55789 2/20 0.47
GAA P10253 1/20 0.47
GPR84 Q9NQS5 1/20 0.47
DRD4 P21917 1/20 0.44
AKR1C3 P42330 3/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8718822 0.90 HTT (0.50) GPR119ALDH1A1GAAHTTSMN1; SMN2
SCHEMBL14884466 0.84 GPR119 (0.48) GPR119ADRB1GAADRD4AKR1C3
SCHEMBL20639686 0.84 GPR119 (0.48) GPR119GAAAKR1C3HTTMAPT
SCHEMBL6174262 0.84 ALDH1A1 (0.47) GPR119ADRB1SIGMAR1ALDH1A1GAA
SCHEMBL3034991 0.80 GPR119 (0.45) GPR119ALDH1A1GFERAKR1C3HTT
SCHEMBL3117217 0.80 MAPT (0.52) HTR3EHTR3BADRB1HTR3AHTR3D
SCHEMBL7887520 0.80 DRD4 (0.60) SIGMAR1ALDH1A1DRD4MAPT
SCHEMBL15912908 0.75 GPR119 (0.44) GPR119ALDH1A1GAADRD4HTT
SCHEMBL8931686 0.75 CHRNB2 (0.52) GPR119HTTMAPT
SCHEMBL6175083 0.75 ALDH1A1 (0.44) ALDH1A1DRD4HTTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261330-A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents RANBAXY LABORATORIES LIMITED (IN) 2005-11-24 US disclosed
EP-1497298-A1 DERIVATIVES OF 2,2,4-TRISUBSTITUTED TETRAHYDROFURAN AS ANTIFUNGAL AGENTS RANBAXY LABORATORIES, LTD. (IN) 2005-01-19 EP disclosed
WO-2003087106-A1 DERIVATIVES OF 2,2,4-TRISUBSTITUTED TETRAHYDROFURAN AS ANTIFUNGAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261330-A1 Derivatives of 2,2,4-trisubstituted tetrahydrofuran an antifungal agents ERG28, DPM1, CYP51A1 GPR119 1617/4885HTR3E 2657/4885HTR3B 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.